Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP)
Condition(s):Retinitis Pigmentosa (RP)Last Updated:February 21, 2021Recruiting
Include Studies Not Open or Pending
Condition(s):Retinitis Pigmentosa (RP)Last Updated:February 21, 2021Recruiting
Condition(s):X-Linked Retinitis PigmentosaLast Updated:April 27, 2022Recruiting
Condition(s):Retinitis PigmentosaLast Updated:March 16, 2022Not yet recruiting
Condition(s):Retinitis PigmentosaLast Updated:September 17, 2021Recruiting
Condition(s):Retinitis PigmentosaLast Updated:April 20, 2022Recruiting
Condition(s):Non-syndromic Retinitis PigmentosaLast Updated:February 4, 2021Recruiting
Condition(s):Retinitis PigmentosaLast Updated:May 17, 2022Recruiting
Condition(s):Retinitis PigmentosaLast Updated:August 23, 2021Recruiting
Condition(s):X-Linked Retinitis PigmentosaLast Updated:March 31, 2022Recruiting
Condition(s):Retinitis PigmentosaLast Updated:June 8, 2015Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.